Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Targeting NADPH oxidase and phospholipases A2 in Alzheimer s disease Simonyi A; He Y; Sheng W; Sun AY; Wood WG; Weisman GA; Sun GYMol Neurobiol 2010[Jun]; 41 (2-3): 73-86Alzheimer's disease (AD) is marked by an increase in the production of extracellular beta amyloid plaques and intracellular neurofibrillary tangles associated with a decline in brain function. Increases in oxidative stress are regarded as an early sign of AD pathophysiology, although the source of reactive oxygen species (ROS) and the mechanism(s) whereby beta amyloid peptides (Abeta) impact oxidative stress have not been adequately investigated. Recent studies provide strong evidence for the involvement of NADPH oxidase and its downstream oxidative signaling pathways in the toxic effects elicited by Abeta. ROS produced by NADPH oxidase activate multiple signaling pathways leading to neuronal excitotoxicity and glial cell-mediated inflammation. This review describes recent studies demonstrating the neurotoxic effects of Abeta in conjunction with ROS produced by NADPH oxidase and the downstream pathways leading to activation of cytosolic phospholipase A(2) (PLA(2)) and secretory PLA(2). In addition, this review also describes recent studies using botanical antioxidants to protect against oxidative damage associated with AD. Investigating the metabolic and signaling pathways involving Abeta NADPH oxidase and PLA(2) can help understand the mechanisms underlying the neurodegenerative effects of oxidative stress in AD. This information should provide new therapeutic approaches for prevention of this debilitating disease.|Alzheimer Disease/*enzymology/*physiopathology/prevention & control[MESH]|Animals[MESH]|Antioxidants/therapeutic use[MESH]|Flavonoids/chemistry/therapeutic use[MESH]|Humans[MESH]|Isoenzymes/genetics/*metabolism[MESH]|Molecular Structure[MESH]|N-Methylaspartate/metabolism/toxicity[MESH]|NADPH Oxidases/genetics/*metabolism[MESH]|Oxidation-Reduction[MESH]|Oxidative Stress[MESH]|Phenols/chemistry/therapeutic use[MESH]|Phospholipases A2/genetics/*metabolism[MESH]|Plant Extracts/chemistry/therapeutic use[MESH]|Polyphenols[MESH]|Receptors, N-Methyl-D-Aspartate/metabolism[MESH]|Signal Transduction/physiology[MESH] |